Paper3978648
Disposition of mitoxantrone in cancer patients.
Alberts DS and 4 others. Cancer Res, 1985. Cited by 79 papers, by iCite.
Cite this record
ConductScience Library. Disposition of mitoxantrone in cancer patients. Papers, record 3978648. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3978648
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anthraquinones | Major topic |
| Antineoplastic Agents | Major topic |
| Neoplasms | Major topic |
| Carbon Radioisotopes | |
| Chromatography, High Pressure Liquid | |
| Female | |
| Humans | |
| Kinetics | |
| Male | |
| Mitoxantrone | |
| Tissue Distribution |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA 17094 | NCI NIH HHS | United States | P01CA017094 | PubMed and NIH | NIH RePORTER |
| CA 23074 | NCI NIH HHS | United States | P30CA023074 | PubMed and NIH | NIH RePORTER |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38904799 | Population pharmacokinetics of free and liposome-encapsulated mitoxantrone in patients with relapsed/refractory lymphoma or small cell lung cancer. | Eur J Clin Pharmacol | 2024 | https://conductscience.org/library/papers/38904799 | PubMed |
| 26966579 | Management of Multiple Sclerosis in the Breastfeeding Mother. | Mult Scler Int | 2016 | https://conductscience.org/library/papers/26966579 | PubMed |
| 24357218 | Mitoxantrone as a substitute for daunorubicin during induction in newly diagnosed lymphoblastic leukemia and lymphoma. | Pediatr Blood Cancer | 2014 | https://conductscience.org/library/papers/24357218 | PubMed |
| 22886782 | Application of Fenton, photo-Fenton, solar photo-Fenton, and UV/H2O2 to degradation of the antineoplastic agent mitoxantrone and toxicological evaluation. | Environ Sci Pollut Res Int | 2013 | https://conductscience.org/library/papers/22886782 | PubMed |
| 22451016 | A physiologically based pharmacokinetic model of mitoxantrone in mice and scale-up to humans: a semi-mechanistic model incorporating DNA and protein binding. | AAPS J | 2012 | https://conductscience.org/library/papers/22451016 | PubMed |
| 16430310 | Mass balance studies, with a focus on anticancer drugs. | Clin Pharmacokinet | 2006 | https://conductscience.org/library/papers/16430310 | PubMed |
| 15089110 | Mitoxantrone: a review of its use in multiple sclerosis. | CNS Drugs | 2004 | https://conductscience.org/library/papers/15089110 | PubMed |
| 11986955 | Pharmacokinetic interactions of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukemia. | Leukemia | 2002 | https://conductscience.org/library/papers/11986955 | PubMed |
| 9310249 | High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule. | Br J Cancer | 1997 | https://conductscience.org/library/papers/9310249 | PubMed |
| 9083333 | Comparative pharmacokinetic and cytotoxic analysis of three different formulations of mitoxantrone in mice. | Br J Cancer | 1997 | https://conductscience.org/library/papers/9083333 | PubMed |
| 8820798 | Mitoxantrone: a review of its pharmacological properties and use in acute nonlymphoblastic leukaemia. | Drugs Aging | 1996 | https://conductscience.org/library/papers/8820798 | PubMed |
| 8699238 | Interstitial chemotherapy with mitoxantrone in recurrent malignant glioma: preliminary data. | J Neurooncol | 1996 | https://conductscience.org/library/papers/8699238 | PubMed |
| 3948308 | Lack of experimental vesicant activity for the anticancer agents cisplatin, melphalan, and mitoxantrone. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3948308 | PubMed |
| 3719894 | The clinical pharmacology of mitozantrone. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3719894 | PubMed |
| 3568271 | Pharmacokinetics of ametantrone acetate (NSC-287513). | Cancer Chemother Pharmacol | 1987 | https://conductscience.org/library/papers/3568271 | PubMed |
| 3397768 | Human central nervous system and plasma pharmacology of mitoxantrone. | J Neurooncol | 1988 | https://conductscience.org/library/papers/3397768 | PubMed |
| 2924379 | Preclinical pharmacology of the anthrapyrazole analog oxantrazole (NSC-349174, piroxantrone). | Cancer Chemother Pharmacol | 1989 | https://conductscience.org/library/papers/2924379 | PubMed |
| 2185907 | Pharmacokinetics and metabolism of mitoxantrone. A review. | Clin Pharmacokinet | 1990 | https://conductscience.org/library/papers/2185907 | PubMed |
| 1760859 | Clinical pharmacokinetics of mitoxantrone in hyperthermic, isolated perfusion of the leg. | Cancer Chemother Pharmacol | 1991 | https://conductscience.org/library/papers/1760859 | PubMed |
| 1711446 | Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer. | Drugs | 1991 | https://conductscience.org/library/papers/1711446 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3978648
GET https://conductscience.org/api/papers/v1/3978648/cited_by?page=2